{"id":1902,"date":"2025-08-13T18:30:04","date_gmt":"2025-08-13T23:30:04","guid":{"rendered":"https:\/\/www.surfacide.com\/?p=1902"},"modified":"2025-08-14T08:29:22","modified_gmt":"2025-08-14T13:29:22","slug":"fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today","status":"publish","type":"post","link":"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/","title":{"rendered":"Entrevista al director ejecutivo de Surfacide con Infection Control Today \u2013 Parte 1: La autorizaci\u00f3n de la FDA marca el comienzo de una nueva era"},"content":{"rendered":"<p>Ha llegado un nuevo cap\u00edtulo en la prevenci\u00f3n de infecciones, y Surfacide est\u00e1 ayudando a definirlo.<\/p>\n\n\n\n<p>En una serie de v\u00eddeos reci\u00e9n lanzada por <em>Control de infecciones hoy<\/em>El fundador y director ejecutivo de Surfacide, Gunner Lyslo, se une a Tori Whitacre Martonicz de IFC para analizar la creaci\u00f3n de la categor\u00eda de reducci\u00f3n microbiana de toda la habitaci\u00f3n (WRMR) por parte de la FDA y lo que significa para el futuro de la luz UV-C en entornos de atenci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" width=\"1024\" height=\"609\" data-src=\"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-1024x609.png\" alt=\"\" class=\"wp-image-1908 lazyload\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/609;width:684px;height:auto\" data-srcset=\"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-1024x609.png 1024w, https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-300x178.png 300w, https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-768x457.png 768w, https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-1536x913.png 1536w, https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM-18x12.png 18w, https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/Screenshot-2025-08-14-at-7.52.08-AM.png 2028w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" \/><\/figure>\n\n\n\n<p><strong>Pulsa el bot\u00f3n de reproducci\u00f3n a continuaci\u00f3n<\/strong> Para ver la Parte 1:<\/p>\n\n\n\n<p><strong>La autorizaci\u00f3n de la FDA marca una nueva era para la desinfecci\u00f3n UVC en el sector sanitario.<\/strong><\/p>\n\n\n\n<p>La conversaci\u00f3n explora la necesidad cr\u00edtica de supervisi\u00f3n de la FDA en un espacio que durante mucho tiempo ha funcionado sin ella, y c\u00f3mo este cambio aporta claridad y est\u00e1ndares m\u00e1s elevados para hospitales, equipos de servicios ambientales y l\u00edderes en prevenci\u00f3n de infecciones.<\/p>\n\n\n\n<p><strong>Los temas clave incluyen:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Qu\u00e9 significa realmente la autorizaci\u00f3n de la FDA para los dispositivos UV-C<\/li>\n\n\n\n<li>Por qu\u00e9 los hospitales deber\u00edan priorizar los sistemas autorizados por la FDA<\/li>\n\n\n\n<li>Lo que los responsables de la toma de decisiones hospitalarias y los l\u00edderes de propiedad intelectual deben saber al evaluar la tecnolog\u00eda UV-C<\/li>\n<\/ul>\n\n\n\n<p>Como una de las primeras empresas en recibir la autorizaci\u00f3n de la FDA bajo la clasificaci\u00f3n WRMR, Surfacide contin\u00faa liderando con ciencia, transparencia y rendimiento comprobado.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.infectioncontroltoday.com\/view\/fda-clearance-marks-new-era-uvc-disinfection-health-care\">Mira ahora<\/a><\/div>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Mant\u00e9ngase atento a m\u00e1s entrevistas de la serie y descubra por qu\u00e9 elegir un sistema UV-C autorizado por la FDA ya no es opcional.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Ha llegado un nuevo cap\u00edtulo en la prevenci\u00f3n de infecciones, y Surfacide est\u00e1 contribuyendo a definirlo. En una nueva serie de videos de Infection Control Today, Gunner Lyslo, fundador y director ejecutivo de Surfacide, se une a Tori Whitacre Martonicz de IFC para hablar sobre la creaci\u00f3n de la categor\u00eda de Reducci\u00f3n Microbiana en Toda la Habitaci\u00f3n (WRMR) por parte de la FDA y sus implicaciones para el futuro [\u2026]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/\">Leer m\u00e1s\u2026<span class=\"screen-reader-text\"> Entrevista del director ejecutivo de Surfacide con Infection Control Today \u2013 Parte 1: La autorizaci\u00f3n de la FDA marca el comienzo de una nueva era<\/span><\/a><\/p>","protected":false},"author":11,"featured_media":1903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"page-templates\/custom-blog.php","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-1902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era - Surfacide<\/title>\n<meta name=\"description\" content=\"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era\" \/>\n<meta property=\"og:description\" content=\"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/\" \/>\n<meta property=\"og:site_name\" content=\"Surfacide\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/surfacide\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-13T23:30:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-14T13:29:22+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png\" \/>\n\t<meta property=\"og:image:width\" content=\"706\" \/>\n\t<meta property=\"og:image:height\" content=\"613\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Alex\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:site\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alex\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/\"},\"author\":{\"name\":\"Alex\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/fe65e6b206719fbe0a6667baed0580ef\"},\"headline\":\"Surfacide CEO Interview With Infection Control Today &#8211; Part 1: FDA Clearance Ushers in a New Era\",\"datePublished\":\"2025-08-13T23:30:04+00:00\",\"dateModified\":\"2025-08-14T13:29:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/\"},\"wordCount\":210,\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/IFC-Part-1-Blog-size-images.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/\",\"name\":\"Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era - Surfacide\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/IFC-Part-1-Blog-size-images.png\",\"datePublished\":\"2025-08-13T23:30:04+00:00\",\"dateModified\":\"2025-08-14T13:29:22+00:00\",\"description\":\"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/IFC-Part-1-Blog-size-images.png\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/IFC-Part-1-Blog-size-images.png\",\"width\":706,\"height\":613},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.surfacide.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surfacide CEO Interview With Infection Control Today &#8211; Part 1: FDA Clearance Ushers in a New Era\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"description\":\"Surfacide\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.surfacide.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"width\":263,\"height\":43,\"caption\":\"http:\\\/\\\/www.surfacide.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/surfacide\",\"https:\\\/\\\/x.com\\\/SurfacideUVC\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/surfacide-llc\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/fe65e6b206719fbe0a6667baed0580ef\",\"name\":\"Alex\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g\",\"caption\":\"Alex\"},\"url\":\"https:\\\/\\\/www.surfacide.com\\\/es\\\/blog-news\\\/author\\\/alextypeamarketing-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era - Surfacide","description":"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/","og_locale":"es_MX","og_type":"article","og_title":"Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era","og_description":"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.","og_url":"https:\/\/www.surfacide.com\/es\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/","og_site_name":"Surfacide","article_publisher":"https:\/\/www.facebook.com\/surfacide","article_published_time":"2025-08-13T23:30:04+00:00","article_modified_time":"2025-08-14T13:29:22+00:00","og_image":[{"width":706,"height":613,"url":"http:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png","type":"image\/png"}],"author":"Alex","twitter_card":"summary_large_image","twitter_creator":"@SurfacideUVC","twitter_site":"@SurfacideUVC","twitter_misc":{"Escrito por":"Alex","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#article","isPartOf":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/"},"author":{"name":"Alex","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/fe65e6b206719fbe0a6667baed0580ef"},"headline":"Surfacide CEO Interview With Infection Control Today &#8211; Part 1: FDA Clearance Ushers in a New Era","datePublished":"2025-08-13T23:30:04+00:00","dateModified":"2025-08-14T13:29:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/"},"wordCount":210,"publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png","articleSection":["Blog"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/","url":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/","name":"Surfacide CEO Interview With Infection Control Today - Part 1: FDA Clearance Ushers in a New Era - Surfacide","isPartOf":{"@id":"https:\/\/www.surfacide.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#primaryimage"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png","datePublished":"2025-08-13T23:30:04+00:00","dateModified":"2025-08-14T13:29:22+00:00","description":"Surfacide CEO Gunner Lyslo speaks with Infection Control Today about FDA clearance for UV-C devices, new WRMR standards, and how Helios+ is setting the benchmark for safe, effective hospital disinfection.","breadcrumb":{"@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#primaryimage","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2025\/08\/IFC-Part-1-Blog-size-images.png","width":706,"height":613},{"@type":"BreadcrumbList","@id":"https:\/\/www.surfacide.com\/blog-news\/fda-clearance-ushers-in-a-new-era-for-uv-c-technology-in-health-care-surfacide-ceo-interview-with-infection-control-today\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.surfacide.com\/"},{"@type":"ListItem","position":2,"name":"Surfacide CEO Interview With Infection Control Today &#8211; Part 1: FDA Clearance Ushers in a New Era"}]},{"@type":"WebSite","@id":"https:\/\/www.surfacide.com\/#website","url":"https:\/\/www.surfacide.com\/","name":"http:\/\/www.surfacide.com","description":"Surfacide","publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.surfacide.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.surfacide.com\/#organization","name":"http:\/\/www.surfacide.com","url":"https:\/\/www.surfacide.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","width":263,"height":43,"caption":"http:\/\/www.surfacide.com"},"image":{"@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/surfacide","https:\/\/x.com\/SurfacideUVC","https:\/\/www.linkedin.com\/company\/surfacide-llc"]},{"@type":"Person","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/fe65e6b206719fbe0a6667baed0580ef","name":"Alex","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ab039e18afc49bb2f085e5721cdac08f23bff5f17afeab1b3efbeec615e46dc1?s=96&d=mm&r=g","caption":"Alex"},"url":"https:\/\/www.surfacide.com\/es\/blog-news\/author\/alextypeamarketing-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/comments?post=1902"}],"version-history":[{"count":0,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media\/1903"}],"wp:attachment":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media?parent=1902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/categories?post=1902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/tags?post=1902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}